Selentium Group AG and Doctis ME Explore Joint Venture for MENA Healthcare
Selentium Group AG is engaged in advanced discussions with Doctis ME to establish a joint venture aimed at delivering AI-powered healthcare technologies throughout the Middle East and North Africa (MENA) region.
The proposed entity will be headquartered in Dubai, United Arab Emirates, serving as a strategic hub for Selentium’s technological and business-to-government (B2G) operations in the region.
Collaboration Focus and Strategic Objectives
This partnership intends to combine Selentium’s robust artificial intelligence ecosystem with Doctis’s specialized medical IT capabilities to drive innovation in healthcare delivery.
- Development of predictive diagnostics and patient monitoring solutions, including platforms such as HippocrAI and Home Medicine.
- Integration of digital health infrastructures across public and private hospitals.
- Research and deployment of AI infrastructure to support national healthcare programs.
- Alignment with Vision 2030 initiatives within Gulf Cooperation Council (GCC) countries.
Executive Commentary
“We see enormous potential in merging Selentium’s AI technologies with Doctis’s medical systems expertise. A joint entity headquartered in Dubai could become a cornerstone for healthcare transformation across MENA.”
Marsel Murtazin, CEO, Selentium Group AGBoard of Directors Perspectives
- Markus Steinmann, CFO: “A joint venture in Dubai strategically positions Selentium for long-term engagement in healthcare modernization across MENA, balancing returns and regional impact.”
- Maria Voronova, CLO: “We are rigorously assessing governance, legal, and data compliance frameworks to ensure alignment with UAE, GCC, and EU regulations.”
- Kenji Tanaka, COO: “Operational synergies are achievable immediately as both teams utilize compatible systems and development methodologies.”
- David Levinson, CTO: “This collaboration will enable deployment of AI products closer to healthcare systems undergoing digital transformation.”
- Liliana Sattor, CBO: “Beyond technology, building trust to empower patients and professionals is central to the joint venture’s mission.”
Strategic Outlook and Next Steps
The initiative underscores Selentium Group AG’s commitment to expanding its footprint in MENA and advancing the region’s shift towards AI-enabled digital healthcare.
Pending approval by the Selentium Board, the joint venture is slated to commence operations in early 2026, establishing a regional center of excellence in Dubai.
FinOracleAI — Market View
The proposed joint venture between Selentium Group AG and Doctis ME represents a strategic alignment that leverages complementary strengths in AI and medical IT to address the growing demand for digital healthcare solutions in MENA.
By situating operations in Dubai, the venture benefits from the city’s robust infrastructure, favorable regulatory environment, and status as a regional technology hub.
- Opportunities: Accelerated adoption of AI-driven diagnostics and patient monitoring; expansion into GCC healthcare modernization programs; potential to influence policy and infrastructure development aligned with Vision 2030.
- Risks: Regulatory and data compliance complexities across multiple jurisdictions; integration challenges between organizational cultures; dependency on timely board approvals and execution.
Impact: This joint venture is poised to positively influence the digital transformation of healthcare across MENA, positioning Selentium as a key regional player in AI healthcare innovation.
